Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47372)
CDC/NIH Web Information Database (32196)
CDC-Authored Genomics and Precision Health Publications Database (5935)
Precision Health Database (63790)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26823)
All of Us Reports and Publications Database (682)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226960)
Epigenetic Epidemiology Publications Database (22825)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last data update: May 08, 2024
. (Total: 63790 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 927 Records)
Next
Query Trace:
Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates
RH Holm et al, Comm Med, April 9, 2024
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response.
Martina Esposito et al. Commun Med (Lond) 2024 4(1) 63
Similar articles in PubMed
Self-copying RNA vaccine wins first full approval: what’s next?
E Dolgin, Nature News, December 6, 2023
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants.
Orlanda Goh et al. JAMA Netw Open 2023 6(11) e2342475
Similar articles in PubMed
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial.
Thiago Carvalho et al. Nat Med 2023 29(10) 2379-2380
Similar articles in PubMed
Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months
R Rubin, JAMA, September 18, 2023
CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season
CDC, September 12, 2023
Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal.
Vítor Borges et al. Nat Med 2023
Similar articles in PubMed
Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies.
Igor M Rouzine et al. Commun Med (Lond) 2023 3(1) 86
Similar articles in PubMed
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.
Abdallah Alami et al. BMJ Open 2023 13(6) e065687
Similar articles in PubMed
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.
Ivan T Lee et al. Nat Commun 2023 14(1) 3631
Similar articles in PubMed
BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
Nick Andrews et al. JAMA 2023
Similar articles in PubMed
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
Kevin C Ma et al. MMWR Morb Mortal Wkly Rep 2023 72(24) 651-656
Similar articles in PubMed
Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination.
Takashi Ishii et al. Sci Rep 2023 13(1) 9607
Similar articles in PubMed
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
Anne M Hause et al. MMWR Morb Mortal Wkly Rep 2023 72(23) 621-626
Similar articles in PubMed
Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity.
He Zhang et al. Nature 2023
Similar articles in PubMed
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
Jennifer DeCuir et al. MMWR Morb Mortal Wkly Rep 2023 72(17) 463-468
Similar articles in PubMed
A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction.
Paulina A Hawkins et al. Microb Genom 9(4)
Similar articles in PubMed
CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine
CDC, April 19, 2023
Personalized vaccine for melanoma may stave off cancer’s return
J Kaiser, Science, April 16, 2023
Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17.
Francisco Tsz Tsun Lai et al. Nature communications 2023 14(1) 1845
Similar articles in PubMed
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Wafaa B Alsoussi et al. Nature 2023
Similar articles in PubMed
Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Kai Wang et al. JAMA network open 2023 6(3) e235755
Similar articles in PubMed
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis.
Deborah Cromer et al. Nature communications 2023 14(1) 1633
Similar articles in PubMed
Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization
M Lipshhuetz et al, Nature Medicine, March 23, 2023
An mRNA Influenza Vaccine - Could It Deliver?
Kathleen M Neuzil et al. The New England journal of medicine 2023 388(12) 1139-1141
Similar articles in PubMed
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.
William J Hulme et al. BMJ (Clinical research ed.) 2023 380e072808
Similar articles in PubMed
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
RL Gelles et al, JAMA Network Open, March 15, 2023
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes.
Ramandip Grewal et al. Nature communications 2023 14(1) 1273
Similar articles in PubMed
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
J Corominas et al, MEDRXIV, March 2, 2023
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
May 08, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP